
Development of predictive in silico model for cyclosporine- and aureobasidin-based P-glycoprotein inhibitors employing receptor surface analysis
Keywords: Cyclosporines; Aureobasidins; P-glycoproteins; Receptor surface analysis; 3D-QSAR